Stellar Biotechnologies Inc Share Price Toronto S.E.
Equities
KLH
CA85855A2039
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.46Cr 1.99Cr 121.63Cr |
---|---|---|---|---|---|
Net income 2024 * | -80L -1.09Cr -67Cr | Net income 2025 * | -1Cr -1.36Cr -83Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.95
x | P/E ratio 2025 * |
-2.72
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.55% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 12/07/12 |
Michael Brooks
PSD | President | 46 | 01/15/01 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 15/23/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 07/19/07 |
Frank Oakes
BRD | Director/Board Member | 73 | 09/10/09 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23/23/23 |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |